Malaysia is George Clinical’s Southeast Asian hub, where we cover neighboring countries of Singapore, Indonesia and the Philippines – accessing a population of almost 400 million multi-ethnic people.
Malaysia is George Clinical’s Southeast Asian hub, where we cover neighbouring countries of Singapore, Indonesia and the Philippines – accessing a population of almost 400 million multi-ethnic people.
Singapore is a recognized destination for clinical trials, yet other countries are fast emerging as more governments commit to streamlining their clinical research industry. Malaysia implements a universal healthcare system that co-exists with a private healthcare system. Malaysia has a multi-ethnic population of over 30 million, with moderate life expectancy and infant mortality rate. The government has committed funding to improve the healthcare systems in order to support medical tourism and clinical research. The network of Clinical Research Centres, as well as Clinical Research Malaysia are part of government effort to improve the country’s infrastructure to support the industry. To date, Malaysia has 90 industry sponsored research (ISR) trial sites which are approved by the Ministry of Health (MOH) and local IRBs/ IECs, consisting 11 prime sites network. They are a mixture of public, teaching and private hospitals, and have participated over 1,000 ISR trials which require ICH GCP compliance.
Central Nervous System 27%
|Population||32.07 million, multi-ethnic|
|Official Language||Bahasa Malaysia (official), English, Chinese (Cantonese, Mandarin, Hokkien, Hakka, Hainan, Foochow), Tamil, Telugu, Malayalam, Panjabi, Thai|
|Hospital Records Language||Mostly English|
|Electronic Hospital Records||Available in selected number of public, teaching and private hospitals only|
|Site Network||90 hospitals sites, mixture of public, teaching hospital and private|
|In-country services||Clinical Operations
|GDP – per capita (US $)||$30,858|
|Health Expenditures||4% of GDP|